A Safety Study of SGN-CD47M in Patients With Solid Tumors

Summary

This trial will study SGN-CD47M to find out whether it is an effective treatment for different types of solid tumors and what side effects (unwanted effects) may occur. The study will have two parts. Part A of the study will find out how much SGN-CD47M should be given for treatment and how often. Part B of the study will use the dose found in Part A and look at how safe and effective the treatment is.

Timeline

Start

2019-07-17

Primary completion

2020-09-14

Completion

2020-09-14

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision based on portfolio prioritization”

Drugs

Indications